Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Novel biomarkers of bronchopulmonary dysplasia and bronchopulmonary dysplasia-associated pulmonary hypertension



To quantify and compare levels of potential biomarkers in neonates with (i) Bronchopulmonary dysplasia (BPD); (ii) BPD-associated pulmonary hypertension (BPD-PH); (iii) PH without BPD; and (iv) neonates without lung disease at ~36 weeks postmenstrual age.

Study design

Multiple potential biomarkers were measured in plasma samples of 90 patients using a multi-spot enzyme-linked immunosorbent assay. Statistical tests done included one-way ANOVA to compare levels of biomarkers between different groups.


Higher levels of ICAM-1 were present in infants with BPD and correlated with its severity. Infants with BPD have significantly higher levels of ANG-2 and lower levels of ANG-1. Infants with PH have higher levels of: IL-6, IL-8, IL-10, and TNF-α. Infants with BPD-PH have significantly lower levels of MCP-1 and higher levels of IL-1β than infants with PH without BPD.


ICAM-1 may be used as a specific biomarker for diagnosis of BPD and its severity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Biomarkers in PC, TC, BPD, PHTN, and BPD-PH (discovery cohort).
Fig. 2: Biomarkers in PC, TC, BPD, PHTN, and BPD-PH (discovery cohort).
Fig. 3: Biomarkers in PC, TC, BPD, PHTN, and BPD-PH (discovery cohort).
Fig. 4: Biomarkers in BPD (validation cohort vs. discovery cohort).

Similar content being viewed by others


  1. Bhandari A, Bhandari V. Biomarkers in bronchopulmonary dysplasia. Paediatr Respir Rev. 2013;14:173–9.

    PubMed  Google Scholar 

  2. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.

    Article  CAS  Google Scholar 

  3. Lal CV, Ambalavanan N. Biomarkers, early diagnosis, and clinical predictors of BPD. Clin Perinatol. 2015;42:739–54.

    Article  Google Scholar 

  4. Piersigilli F, Lam TT, Vernocchi P, Quagliariello A, Putignani L, Aghai ZH, et al. Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics. Metabolomics. 2019;15:20.

    Article  CAS  Google Scholar 

  5. Piersigilli F, Bhandari V. Biomarkers in neonatology: the new “omics” of bronchopulmonary dysplasia. J Matern Fetal Neonatal Med. 2016;29:1758–64.

    CAS  PubMed  Google Scholar 

  6. Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed. 2008;93:F455–61.

    Article  CAS  Google Scholar 

  7. O’Connor MG, Suthar D, Vera K, Slaughter JC, Maitre NL, Steele S, et al. Pulmonary hypertension in the premature infant population: analysis of echocardiographic findings and biomarkers. Pediatric Pulmonol. 2018;53:302–9.

    Article  Google Scholar 

  8. Littler DR, Harrop SJ, Goodchild SC, Phang JM, Mynott AV, Jiang L, et al. The enigma of the CLIC proteins: ion channels, redox proteins, enzymes, scaffolding proteins? FEBS Lett. 2010;584:2093–101.

    Article  CAS  Google Scholar 

  9. Singh H. Two decades with dimorphic Chloride Intracellular Channels (CLICs). FEBS Lett. 2010;584:2112–21.

    Article  CAS  Google Scholar 

  10. Wojciak-Stothard B, Abdul-Salam VB, Lao KH, Tsang H, Irwin DC, Lisk C, et al. Aberrant chloride intracellular channel 4 expression contributes to endothelial dysfunction in pulmonary arterial hypertension. Circulation. 2014;129:1770–80.

    Article  CAS  Google Scholar 

  11. Gururaja Rao S, Ponnalagu D, Patel NJ, Singh H. Three decades of chloride intracellular channel proteins: from organelle to organ physiology. Curr Protoc Pharmacol. 2018;80:11.21.11–17.

    Article  Google Scholar 

  12. Ren G, Roberts AI, Shi Y. Adhesion molecules: key players in mesenchymal stem cell-mediated immunosuppression. Cell Adhes Migr. 2011;5:20–2.

    Article  Google Scholar 

  13. Glaser K, Speer CP. Pre and postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. In: Bhandari V editor. Bronchopulmonary Dysplasia. Cham: Springer International Publishing; 2016, pp. 55–77.

  14. Ramsay PL, O’Brian Smith E, Hegemier S, Welty SE. Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1. Pediatrics. 1998;102:927–32.

    Article  CAS  Google Scholar 

  15. Welty SE, Rivera JL, Elliston JF, Smith CV, Zeb T, Ballantyne CM, et al. Increases in lung tissue expression of intercellular adhesion molecule-1 are associated with hyperoxic lung injury and inflammation in mice. Am J Respir Cell Mol Biol. 1993;9:393–400.

    Article  CAS  Google Scholar 

  16. Ambalavanan N, Carlo WA, D’Angio CT, McDonald SA, Das A, Schendel D, et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics. 2009;123:1132–41.

    Article  Google Scholar 

  17. Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med. 2003;47:149–61.

    CAS  PubMed  Google Scholar 

  18. Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G, et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Therap. 2005;314:738.

    Article  CAS  Google Scholar 

  19. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med. 2006;12:1286–93.

    Article  CAS  Google Scholar 

  20. Thomas W, Seidenspinner S, Kramer BW, Wirbelauer J, Kawczyńska-Leda N, Szymankiewicz M, et al. Airway angiopoietin-2 in ventilated very preterm infants: Association with prenatal factors and neonatal outcome. Pediatr Pulmonol. 2011;46:777–84.

    Article  Google Scholar 

  21. Mohamed WA, Niyazy WH, Mahfouz AA. Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants. J Tropical Pediatrics. 2011;57:385–8.

    Article  Google Scholar 

  22. Baier RJ, Loggins J, Kruger TE. Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum. J Investig Med. 2001;49:362–9.

    Article  CAS  Google Scholar 

  23. Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol. 2004;37:137–48.

    Article  Google Scholar 

  24. Jackson W, Laughon MM. Biomarkers of bronchopulmonary dysplasia. In: Bhandari V editor. Bronchopulmonary dysplasia. Cham: Springer International Publishing; 2016, pp. 129–48.

  25. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ. Increase in interleukin (IL)-1β and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res. 1996;40:250.

    Article  CAS  Google Scholar 

  26. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Investig. 2001;107:1529–36.

    Article  CAS  Google Scholar 

  27. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res. 2009;104:236–44.

    Article  CAS  Google Scholar 

  28. Groth A, Vrugt B, Brock M, Speich R, Ulrich S, Huber LC. Inflammatory cytokines in pulmonary hypertension. Respir Res. 2014;15:47.

    Article  Google Scholar 

  29. Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis. 2005;8:63–71.

    Article  CAS  Google Scholar 

  30. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331–44.

    Article  CAS  Google Scholar 

  31. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res. 1996;39:966–75.

    Article  CAS  Google Scholar 

  32. Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010;122:920–7.

    Article  CAS  Google Scholar 

Download references


This work was supported by a grant from the American Heart Association Grant-in-Aid 16GRNT29430000, and National Institute of Health R01-HL133050, to HS.

Author information

Authors and Affiliations



MS designed the study, performed the experiments, carried out the statistical analysis and drafted the initial manuscript. BY did the data collection for the study. PD and DS performed the experiments, assisted with data analysis and reviewed and revised the manuscript. DP and HS performed the experiments, reviewed and revised the manuscript. LN helped design the study, coordinated sample collection, reviewed and revised the manuscript. VB conceptualized and designed the study, supervised the experiments and statistical analysis, reviewed and revised the manuscript for important intellectual content. All authors approved the final manuscript as submitted.

Corresponding author

Correspondence to Vineet Bhandari.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sahni, M., Yeboah, B., Das, P. et al. Novel biomarkers of bronchopulmonary dysplasia and bronchopulmonary dysplasia-associated pulmonary hypertension. J Perinatol 40, 1634–1643 (2020).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links